Cirrhosis in over 16s: assessment and management.

  • Guideline Summary
  • NGC:009796
  • 1998 Jan (revised 2013 Feb)

Management of adult patients with ascites due to cirrhosis: update 2012.

  • Guideline Summary
  • NGC:010545
  • 2012 Aug

SonoVue (sulphur hexafluoride microbubbles) – contrast agent for contrast-enhanced ultrasound imaging of the liver.

  • Guideline Summary
  • NGC:011021
  • 2016 Jul 6

Non-alcoholic fatty liver disease (NAFLD): assessment and management.

Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection.

  • Guideline Summary
  • NGC:010213
  • 2008 Jun (revised 2014)

Esophageal varices.

  • Guideline Summary
  • NGC:010903
  • 2016 Jan

AASLD guidelines for treatment of chronic hepatitis B.

  • Guideline Summary
  • NGC:009204
  • 2012 Jun

NASPGHAN practice guidelines: diagnosis and management of hepatitis C infection in infants, children, and adolescents.

  • Guideline Summary
  • NGC:009150
  • 2002 (revised 2012 Jun)

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.

  • Guideline Summary
  • NGC:010448
  • 1998 (revised 2014)

ACR Appropriateness Criteria® liver lesion — initial characterization.

  • Guideline Summary
  • NGC:009890
  • 2013 Jan

Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.

British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013.

VA/DoD clinical practice guideline for the management of substance use disorders.

Hepatitis B virus.

Management of hepatitis C. A national clinical guideline.

  • Guideline Summary
  • NGC:009937
  • 2004 Mar 16 (revised 2013 Sep 3)

Screening for hepatitis C virus infection in adults: U.S. Preventive Services Task Force recommendation statement.

  • Guideline Summary
  • NGC:009072
  • 2012 Apr

Boceprevir for the treatment of genotype 1 chronic hepatitis C.

  • Guideline Summary
  • NGC:009076
  • 2012 Apr

Telaprevir for the treatment of genotype 1 chronic hepatitis C.